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Abstract
Background: Metabolic profiling holds promise with regard to deepening our understanding of infection biology and
disease states. The objectives of our study were to assess the global metabolic responses to an Echinostoma caproni
infection in the mouse, and to compare the biomarkers extracted from different biofluids (plasma, stool, and urine) in terms
of characterizing acute and chronic stages of this intestinal fluke infection.
Methodology/Principal Findings: Twelve female NMRI mice were infected with 30 E. caproni metacercariae each. Plasma,
stool, and urine samples were collected at 7 time points up to day 33 post-infection. Samples were also obtained from non-
infected control mice at the same time points and measured using
1H nuclear magnetic resonance (NMR) spectroscopy.
Spectral data were subjected to multivariate statistical analyses. In plasma and urine, an altered metabolic profile was
already evident 1 day post-infection, characterized by reduced levels of plasma choline, acetate, formate, and lactate,
coupled with increased levels of plasma glucose, and relatively lower concentrations of urinary creatine. The main changes
in the urine metabolic profile started at day 8 post-infection, characterized by increased relative concentrations of
trimethylamine and phenylacetylglycine and lower levels of 2-ketoisocaproate and showed differentiation over the course
of the infection.
Conclusion/Significance: The current investigation is part of a broader NMR-based metabonomics profiling strategy and
confirms the utility of this approach for biomarker discovery. In the case of E. caproni, a diagnosis based on all three
biofluids would deliver the most comprehensive fingerprint of an infection. For practical purposes, however, future
diagnosis might aim at a single biofluid, in which case urine would be chosen for further investigation, based on quantity of
biomarkers, ease of sampling, and the degree of differentiation from the non-infected control group.
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Introduction
An estimated 40 million individuals are infected with food-borne
trematodes and, in many parts of the world, the diseases caused by
these infections are emerging [1]. Yet, food-borne trematodiases are
so-called neglected tropical diseases [2]. An infection with food-
borne trematodes is acquired by the consumption of the larval stage
of the parasite, present in aquatic food products (e.g., freshwater fish,
crustacean, and water plants). Adult flukes reside either in the
intestine(e.g.,Echinostomaspp.),thelung(e.g.,Paragonimusspp.),orthe
liver (e.g., Clonorchis sinensis, Fasciola spp., Opisthorchis spp.) and can
lead to various forms of pathology [2,3].
A light infection with the intestinal fluke Echinostoma spp. in
humans causes no marked deviation from the healthy state in the
majority of cases, whereas the clinical symptoms due to a heavy
infection include abdominal pain, violent diarrhea, anorexia, easy
fatigue, and changes in the intestinal architecture, such as
intestinal erosions, damage of intestinal mucosa, and catarrhal
inflammation [4]. Histopathological investigations in mice and
humans infected with Echinostoma spp. have revealed atrophied,
fused and eroded villi, and a crypt hyperplasia in both lightly and
heavily infected subjects [5–7].
At present, the most widely used diagnosis for infections with
Echinostoma spp. and other food-borne trematodes, is by means of
microscopic examination of stool samples for the presence of
parasite eggs. However, light infection intensities, particularly at
the onset of disease are often missed by this diagnostic approach.
In addition, the detection of echinostome eggs in stool samples
varies greatly due to species-dependent differences in egg laying
capacity. Other means for diagnosis of food-borne trematode
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enzyme-linked immunosorbent assay (ELISA) [8] or polymerase
chain reaction (PCR) [9], which depend on specificity of antigens
and primers, respectively.
In the current study we applied a combination of
1H nuclear
magnetic resonance (NMR) spectroscopy and multivariate statis-
tical analysis to identify candidate biomarkers of an E. caproni
infection and disease states in the mouse, by metabolic profiling of
blood plasma, stool, and urine samples. E. caproni is a suitable
trematode model that has been widely and effectively used in the
laboratory for drug screening, and to deepen our understanding of
the immunology and pathology of echinostomes and other food-
borne trematodes in the vertebrate host [10–12]. NMR spectros-
copy delivers a snapshot of the metabolite composition of biofluids,
tissues and even bone, and has found a large array of applications
in biology and medicine, such as the detection and differentiation
of coronary heart disease [13], and biomarker identification in
schizophrenia patients [14]. The systemic metabolic profile of a
biological sample is of special interest, because it can be
characteristic of the entire organism, and hence finds increasing
application in systems biology [15]. The use of multivariate
statistical methods to analyze and interpret complex spectral
datasets makes it possible to deal with large sample data banks,
and to detect differences between physiologically or pathologically
distinct states. Candidate biomarkers can be identified from these
models, taking into consideration intra-group variations, sample
preparation methods, and spectral data acquisition. Thus far, we
have characterized the global metabolic responses to several
parasitic infections in rodents, namely (i) Schistosoma mansoni in the
mouse [16], (ii) Schistosoma japonicum in the hamster [17], (iii)
Trichinella spiralis in the mouse [18], (iv) Trypanosoma brucei brucei in
the mouse [19], and (v) Plasmodium berghei in the mouse [56] mainly
based on the urine and/or blood plasma metabolite profiles. Here
we extend these initial host-parasite models to consider the relative
merit of using biomarkers derived from a combined biological
sample profile, and apply a metabolic profiling strategy for the first
time to a food-borne trematode.
Materials and Methods
E. caproni-mouse model and animal husbandry
Our experiments were carried out in accordance with Swiss
cantonal and national regulations on animal welfare (permission
no. 2081). Female NMRI mice (n=24) were purchased from RCC
(Itingen, Switzerland), and housed in groups of 4 in macrolon
cages under environmentally-controlled conditions (temperature:
,25uC; humidity: ,70%; light-dark cycle: 12–12 h). Mice had
free access to commercially available rodent food from Nafag
(Gossau, Switzerland) and community tap water supply.
Mice were 5 to 6-week-old at the onset of the experiments and
had an average weight of 25.5 g (standard deviation (SD)=0.9 g).
Half of the mice remained uninfected throughout the study and
served as controls. The other 12 mice were orally infected with 30
E. caproni metacercariae each (provided by B. Fried; Lafayette
College, Easton, PA, United States of America) [20] on designated
study day 0, which took place 1 week after arrival of animals to
provide sufficient acclimatization time, and hence minimize stress-
related impact on the metabolic profiles. Upon dissection of mice
at the end of the experiment, however it was found that no
infection had been established in 4 animals. Therefore these 4
mice were excluded from any further analysis.
Collection of biofluids
Blood plasma, stool and urine samples were collected over a 33-
day time course at 7 distinct sampling points (days 1, 5, 8, 12, 19, 26,
and 33 post-infection), representative of different stages in the life of
the E. caproni fluke, including acute and chronic infection stages.
Collection was carried out between 08:00 and 10:00 hours in order
to avoid potential variation of metabolite concentrations due to
diurnal fluctuations. Stool and urine samples were collected into
Petri dishes by gently rubbing the abdomen of the mice, and were
immediately transferred into separate Eppendorf tubes and kept at
240uC. Blood samples (40–50 ml) were collected from the tail tip of
each mouse into haematocrit tubes with sodium [Na] heparin-coat.
Tubes were placed ina centrifuge (model 1–15, Sigma; Osterode am
Harz, Germany) operated at 4,000 g for 4 min in order to separate
plasma from red blood cells. The packed cell volume (PCV), i.e.,
length of red blood cells column in the microcapillary versus total
length of blood sample column, was determined and expressed as
percentage. Subsequently, the plasma fraction (,20 ml) was
transferred into a separate Eppendorf tube and kept at 240uC.
Animals were weighed at each sampling point, using a Mettler
balance (model K7T; Greifensee, Switzerland).
Mice were killed 36 days post-infection, using CO2. The small
intestine was removed, and adult worms recovered from the ileum
and jejunum and counted. Biological samples and an E. caproni
specimen were forwarded to Imperial College London (United
Kingdom) on dry ice and stored at 240uC prior to processing for
1H NMR spectroscopic data acquisition.
Preparation of biofluids and E. caproni homogenate
Urine samples were prepared with a phosphate buffer (pH 7.4)
containing 50% D2O (Goss Scientific Instruments; Chelmsford,
United Kingdom) as a field frequency lock and 0.01% sodium 3-
(trimethylsilyl) [2,2,3,3-
2H4] propionate (TSP) (Cambridge Isotope
Laboratories Inc.; Andover, MA, United States of America), as a
chemical shift reference (d 0.0). An aliquot of 25 ml of urine was
added to 25 ml phosphate buffer. Plasma samples were prepared
by adding 30 ml of 0.9% saline made up in 50% D2O into the
Eppendorf tubes containing ,20 ml of plasma. Because of the
limited volumes of urine and plasma, samples were transferred
Author Summary
Consumption of raw fish and other freshwater products
can lead to unpleasant worm infections. Indeed, such
worm infections are of growing public health and
veterinary concern, but they are often neglected, partially
explained by the difficulty of accurate diagnosis. In the
present study we infected 12 mice with an intestinal worm
(i.e., Echinostoma caproni) and collected blood, stool, and
urine samples 7 times between 1 and 33 days after the
infection. At the same time points, blood, stool, and urine
were also sampled from 12 uninfected mice. These biofluid
samples were examined with a spectrometer and data
were analyzed with a multivariate approach. We observed
important differences between the infected and the
uninfected control animals. For example, we found an
increased level of branched chain amino acids in the stool
of infected mice and subsequent depletion in blood
plasma. Additionally, we observed changes related to a
disturbed intestinal bacterial composition, particularly in
urine and stool. The combination of results from the three
types of biofluids gave the most comprehensive charac-
terization of an E. caproni infection in the mouse. Urine
would be the biofluid of choice for diagnosis of an
infection because the ease of sample collection and the
high number and extent of changed metabolites.
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France) using a micro-syringe.
Stool samples were prepared with the same buffer as for urine
but using 90% D2O to reduce the water content. Two pellets of
stool were mashed with 700 ml buffer and sonicated for 30 min to
inactivate gut bacteria and achieve biochemical stability in the
sample. The samples were then centrifuged at 10,000 g for 2 min,
and 550–600 ml of the supernatant was transferred into a new
Eppendorf tube and stored at 240uC. Shortly before data
acquisition, the stool supernatant was defrosted, centrifuged and
transferred into NMR tubes of 5 mm outer diameter.
A tissue extraction was performed on the E. caproni specimen for
1H NMR spectroscopic analysis. The adult E. caproni fluke was
mashed in 1 ml of chloroform with a glass mortar and pestle. A total
of 1 ml of methanol and 1 ml of water were added, and this mixture
was transferred into a glass tube. Another 0.5 ml of each liquid was
used to rinse the mortar and transferred into the same glass tube.
The mixture was centrifuged at 2,500 g for 30 min. The aqueous
and the chloroform phases were transferred into a new glass tube
each, chloroform was evaporated over night and the aqueous phase
was lyophilized. Prior to
1H NMR data acquisition, the powder
obtained from the aqueous phase was resolved in 550 mlp h o s p h a t e
Figure 1. Aliphatic regions of representative 600 MHz
1H-NMR 1D spectra of biological samples obtained from an uninfected control
mouse, aged 7–8 weeks. Spectra of urine (A), plasma (B) and fecal water (C) are shown. Additionally, the same region of a 600 MHz
1H NMR 1D
spectrum of an E. caproni extract is depicted (D). Key: 2-og, 2-oxoglutarate; 3-hb, 3-hydroxybutyrate; 2-kic, 2-ketoisocaproate; 2-kiv, 2-ketoisovalerate;
b-glu, b-glucose; aa, amino acids; ace, acetate; ala, alanine; arg, arginine; asn, asparagine; asp, aspartate; bcaa, branched chain amino acids; bet,
betaine; but, butyrate; cit, citrate; cho, choline; cre, creatine; crt, creatinine; dht, dihydroxythymine; dma, dimethylamine; dmg, dimethylglycine; glc,
glycolate; gln, glutamine; glu, glutamate; gly, glycine; gpc, glycerophosphocholine; gua, guanidinoacetate; hip, hippurate; lac, lactate; leu, leucine; lys,
lysine; mea, methylamine; meg, methylguanidine; mel, methanol; met, methionine; nmna, N-methyl-nicotinamide; phe, phenylalanine; pip,
pipecolate; pro, proline; p5p, pyridoxamine-5-phosphate; pyr, pyruvate; scy, scyllo-inositol; suc, succinate; tau, taurine; thr, threonine; tma,
trimethylamine; tmao, trimethylamine-N-oxide; ure, ureidopropanoate.
doi:10.1371/journal.pntd.0000254.g001
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was dissolved in deuterated chloroform (CDCl3).
Acquisition of spectral data
1H NMR spectra from plasma, stool, and urine samples, and
the E. caproni extract were recorded on a Bruker DRX 600 NMR
spectrometer, operating at 600.13 MHz for proton frequency
(Bruker; Rheinstetten, Germany). A Bruker 5 mm triple resonance
probe with inverse detection was used, employing a standard
NMR 1-dimensional (1D) experiment with pulse sequence [recycle
delay (RD)-90u-t1-90u-tm-90u-ACQ], setting t1 to 3 ms, and using a
mixing time (tm) of 150 ms. Water suppression was achieved with
irradiation of the water peak during the RD set to 2 s and mixing
time. The 90u pulse length was adjusted to ,10 ms. A total of 256
transientswere collected into,32,000 data pointsfor eachspectrum
with a spectral width of 20 ppm. For plasma, two additional pulse
programs were applied, namely Carr-Purcell-Meiboom-Gill
(CPMG), and diffusion edited spectroscopy [21] to focus on the
low and high molecular weight components of the plasma profile,
respectively. All free induction decays (FIDs) were multiplied by an
exponential function equivalent to a 0.3 Hz line-broadening factor
prior to Fourier transformation.
Assignments of the spectral peaks were made from literature
values [22–25] and confirmed via statistical total correlation
spectroscopy (STOCSY) in MATLAB [26] and via standard 2-
dimensional (2D) NMR experiments conducted on selected samples,
including correlation spectroscopy (COSY), total correlation spec-
troscopy (TOCSY), and J-resolved NMR spectra [27,28].
Figure 2. Aromatic regions of representative 600 MHz
1H-NMR
1D spectra of biological samples obtained from an uninfected
control mouse, aged 7–8 weeks. Spectra of urine (A), plasma (B) and
fecal water (C) are shown. Additionally, the same region of a 600 MHz
1H NMR 1D spectrum of an E. caproni extract is depicted (D). Key: a-glu,
a-glucose; alt, alantoin; for, formate; fum, fumarate; hip, hippurate; his,
histidine; hom, homocarnosine; ind, indoxylsulfate; nmna, N-methyl-
nicotinamide; pag, phenylacetylglycine; phe, phenylalanine; trp, tryp-
tophan; tyr, tyrosine; ura, uracil; uri, uridine; uro, urocanate.
doi:10.1371/journal.pntd.0000254.g002
Figure 3. PCA trajectory plot of urine (A), plasma (B) and fecal
water spectra (C) obtained from the mean PC1 and PC2 values
for the E. caproni-infected mice over a 33-day period. The
collection of the biofluids was performed at days 1, 5, 8, 12, 19, 26, and
33 post-infection. The ellipses in the 3D plots (Figures 3B and C) are for
illustration purposes only to denote time points which become distinct
from controls in 3D but are not clearly resolved in two dimensions, and
are not based on statistical boundaries.
doi:10.1371/journal.pntd.0000254.g003
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Data processing was as follows. First, spectra were corrected for
phase and baseline distortions with an in-house developed
MATLAB script. Second, the region containing the water/urea
resonances (i.e., d 4.2–6.3 in urine, d 4.4–5.2 in plasma, and d 4.7–
5.5 in stool extracts) was excluded. Third, the spectra were
normalized over the total sum of the remaining spectral area.
Analysis of the spectral data was performed with principal
component analysis (PCA) [29], projection to latent structure
discriminant analysis (PLS-DA) and orthogonal (O)-PLS-DA [30].
PCA was used to explore any intrinsic similarity between samples.
PCA models cannot be over-fitted since no prior information on
infection status is included in the model. PLS-DA was then used to
apply knowledge of infection status to optimize separation of classes
and recovery of candidate biomarkers [30]. O-PLS-DA includes an
orthogonal data filter in the PLS-DA and was used to further
improve the extraction of infection-related biomarkers by removing
the influence of systematic variation not related to infection status.
The weight of contribution of the peaks is indicated by the color
scale, whereby red symbolizes relatively high correlation with
Table 1. List of main metabolites found in urine over a 33-day study period in NMRI female mice.
Metabolite
Maximal time of
metabolic change Chemical moiety Chemical shift in ppm and multiplicity
2-hydroxyisobutyrate 26CH3 1.36(s)
2-ketoisocaproate Q (d12) CH2, CH, 26CH3 2.61(d), 2.10(m), 0.94(d)
2-oxoglutarate b-CH2, c-CH2 3.02(t), 2.50(t)
acetate Q (d8) CH3 1.91(s)
alanine a-CH, b-CH3 3.81(q), 1.48(d)
allantoin CH 5.40(s)
citrate 1-CH2, 3-CH2 2.69(d), 2.54(d)
creatine Q (d8) CH3,C H 2 3.04(s), 3.93(s)
creatinine CH3,C H 2 3.05(s), 4.06(s)
dimethylamine 26CH3 2.71(s)
dimethylglycine 26CH3,C H 2 2.89(s), 3.71(s)
formate CH 8.45(s)
fumarate CH 6.53(s)
a-glucose q (d1); Q (d12)* 1-CH, 2-CH, 3-CH, 4-CH, 5-CH, half 6-CH2, half 6-CH2 5.24(d), 3.56(dd), 3.70(t), 3.40(t), 3.83(m), 3.72(dd),
3.85(m)




hippurate Q (d33) CH2, 2,6-CH, 3,5-CH, 4-CH 3.97(d), 7.84(d), 7.55(t), 7.64(t)
indoxylsulfate 5-CH, 6-CH, 4-CH, 7-CH 7.20(t), 7.27(t), 7.51(d), 7.70(d)
lactate CH, CH3 4.12(q), 1.33(d)
mannitol q (d12) 26a-CH2,2 6b-CH, 26c-CH 3.78(m), 3.88(dd), 3.68(dd)
methylcrotonate b-CH, c-CH3, c9-CH3 1.66(s), 1.70(s), 1.71(s)
methylamine CH3 2.61(s)
methylguanidine CH3 2.83(s)
N-methyl-nicotinamide CH3, 6-CH, 2-CH, 5-CH, 4-CH 4.48(s), 8.97(d), 9.28(s), 8.19(t), 8.90(d)
p-cresolglucuronide q (d12) 2,6-CH, 3,5-CH, CH3 7.06(d), 7.23(d), 2.30(s)
phenylacetylglycine q (d26) 2,6-CH, 3,5-CH, Ph-CH2, N-CH2 7.43(m), 7.37(m), 3.75(d), 3.68(s)
pyridoxamine-5-phosphate OCH2,C H 2N, CH3 7.67(s), 4.34(s), 2.48(s)
succinate q (d33) 26CH2 2.41(s)
taurine Q (d19) CH2N, CH2S 3.27(t), 3.43(t)
trimethylamine q (d12) 36CH3 2.88(s)
trimethylamine-N-oxide q (d12) 36CH3 3.27(s)
ureidopropanoate a-CH2, b-CH2 2.38(t), 3.3(t)
urocanate a-CH, b-CH, 5-CH, 2-CH 6.40(d), 7.13(d), 7.41(s), 7.89(s)
The arrows show whether the metabolic change, associated with an E. caproni infection, is significantly increased (q) or decreased (Q) in infected mice compared to
non-infected control mice and the numbers, next to the arrows indicate the day of maximum significance. The p-values for the changing metabolites were assessed
using a non-parametric 1-way analysis of variance (Mann-Whitney U) test in MATLAB, based on the integrals of the selected peaks and were all in the range of 0.001 to
0.05.
doi:10.1371/journal.pntd.0000254.t001
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metaboliteswhich contributed thegreatest weighttotheO-PLS-DA
coefficient plot were identified (Tables 1–3).
The NMR spectral data were used as the X-matrix and class
information (infected or non-infected control) as the Y-matrix to
build the O-PLS-DA models. A model consisting of one PLS
component and one orthogonal component was generated using
7-fold cross validation.
Finally, in order to more accurately profile the temporal
behavior of the discriminatory metabolites characterizing an
E. caproni infection, computational integration was performed on
selected resonances. Resonances from several of the metabolites in
each sample, which showed infection-dependent variations, were
integrated using an automated curve fitting program. The relative
concentration in relation to the total spectral integral, subsequent
to removal of the water resonance, was determined. This was
performed in MATLAB using a previously published method [31],
and further modified by a colleague (K. Veselkov; Imperial
College London, UK). The p-values for the metabolites were
assessed using a non-parametric 1-way analysis of variance (Mann-
Whitney U) test in MATLAB.
Results
Physiological monitoring of mice
E. caproni-infected mice showed no visible sign of ill-health over
the course of the experiment. The mean weight and mean PCV of
E. caproni-infected (n=8) and non-infected control mice (n=12)
did not differ at any of the time points investigated. The PCV
values maintained a constant level throughout the experiment
(49.6–55.1%). Upon dissection and worm count, an infection was
confirmed in 8 out of the 12 mice (average worm count 26.5,
SD=12.0, range: 10–44 worms). The 4 animals with no
established infection were excluded from further analyses.
Table 2. List of main plasma metabolites found in mice over a 33-day study period.
Metabolite
Maximal time of
metabolic change Chemical moiety Chemical shift in ppm and multiplicity
2-ketoisovalerate CH, 26CH3 3.02(m), 1.13(d)
3-hydroxybutyrate half a-CH2, half a-CH2, b-CH, c-CH3 2.32(m), 2.42(m), 4.16(m), 1.21(d)
acetate q (d12) CH3 1.91(s)
acetoacetate a-CH2, c-CH3 2.29(s), 3.45(s)
alanine a-CH, b-CH3 3.81(q), 1.48(d)
allantoin CH 5.40(s)
choline Q (d33) 36CH3, a-CH2, b-CH2 3.21(s), 4.07(m), 3.52(m)
citrate 1-CH2, 3-CH2 2.69(d), 2.54(d)
creatine Q (d12) CH3,C H 2 3.04(s), 3.93(s)
dihydroxythymine CH2, CH, CH3 3.17(m), 2.47(m), 1.07(d)
formate q (d12) CH 8.45(s)
a-glucose q (d1); Q (d12)* 1-CH, 2-CH, 3-CH, 4-CH, 5-CH, half 6-CH2, half 6-CH2 5.24(d), 3.56(dd), 3.70(t), 3.40(t), 3.83(m), 3.72(dd),
3.85(m)
b-glucose q (d1); Q (d12)* 1-CH, 2-CH, 3-CH, 4-CH, 5-CH, half 6-CH2, half 6-CH2 4.65(d), 3.25(dd), 3.47(t), 3.40(t), 3.47(ddd),
3.78(dd), 3.90(dd)
glycerophosphocholine Q (d12) 36CH3, half a-CH2, half a-CH2, half b-CH2, half b-CH2, c-CH2 3.23(s), 4.32(t), 3.60(dd), 3.68(t), 3.89(m), 3.72(dd)
isoleucine Q (d33) a-CH, b-CH, half c-CH2, half c-CH2, d-CH3, b-CH3 3.68(d), 1.93(m), 1.25(m), 1.47(m), 0.99(d), 1.02(d)
lactate CH, CH3 4.12(q), 1.33(d)
leucine Q (d33) a-CH, b-CH2, c-CH, d-CH3, d-CH3 3.72(t), 1.63(m), 1.69(m), 0.91(d), 0.94(d)
methionine a-CH, b-CH2, c-CH2,C H 3 3.87(m), 2.10(m), 2.65(dd), 2.15(s)
scyllo-inositol 66CH 3.35(s)
valine Q (d33) a-CH, b-CH, c-CH3, c9-CH3 3.62(d), 2.28(m), 0.98(d), 1.03(d)
lipid fraction q CH3 0.84(t)
lipid fraction q (CH2)n 1.25(m)
lipid fraction q b-CH2CH2CO 1.57(m)
lipid fraction q CH2C=C 1.97(m), 2.00(m)
lipid fraction q CH2CO 2.23(m)
lipid fraction q C=CCH2C=C 2.69(m), 2.71(m), 2.72(m)
lipid fraction q CH=CH 5.23(m), 5.26(m), 5.29(m)
Arrows indicate significantly changing substances comparing plasma of E. caproni-infected mice with non-infected control mice (q, increased; Q, decreased in infected
animals) and the numbers in brackets indicate the day of maximum significance.
*glucose was the only metabolite found, which changed its directionality with time, i.e.,
it increased significantly after one day of infection and at day 12 post-infection was present in significantly lower concentrations, compared to uninfected control mice.
The p-values for the changing metabolites were assessed using a non-parametric 1-way analysis of variance (Mann-Whitney U) test in MATLAB, based on the integrals of
the selected peaks and were all in the range of 0.001 to 0.05.
doi:10.1371/journal.pntd.0000254.t002
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Metabolite
Maximal time of
metabolic change Chemical moiety Chemical shift in ppm and multiplicity
2-hydroxyisovalerate a-CH, b-CH, c-CH3, c9-CH3 3.85(d), 2.02(m), 0.79(d), 0.84(d)
2-ketoisocaproate CH2, CH, 26CH3 2.61(d), 2.10(m), 0.94(d)
2-ketoisovalerate CH, 26CH3 3.02(m), 1.13(d)
3-aminopropionic acid a-CH2, b-CH2 2.56(t), 3.19(t)
3-hydroxyphenylpropionate a-CH2, b-CH2, 2-CH 2.85(t), 2.47(m), 6.80(m)
2-oxoisoleucine CH, half c-CH2, half c-CH2, d-CH3, b-CH-CH3 2.93(m), 1.70(m), 1.46(m), 0.90(t), 1.10(d)
5-aminovalerate q (d26) 5-CH2, 2-CH2, 3,4-CH2 3.02(t), 2.24(t), 1.65(m)
acetate Q (d12) CH3 1.91(s)
alanine Q (d12) a-CH, b-CH3 3.81(q), 1.48(d)
arginine a-CH, b-CH2, c-CH2, d-CH2 3.76(t), 1.89(m), 1.59(m), 3.17(t)
asparagine a-CH, half b-CH2, half b-CH2 4.01(m), 2.87(dd), 2.96(dd)
aspartate a-CH, half b-CH2, half b-CH2 3.92(m), 2.70(m), 2.81(m)
bile acids CH3 0.70(m)
butyrate Q (d26) a-CH2, b-CH2, c-CH3 2.16(t), 1.56(m), 0.90(t)
ethanolamine NH-CH2, HO-CH2 3.15(t), 3.78(t)
formate CH 8.45(s)
fumarate CH 6.53(s)
a-glucose 1-CH, 2-CH, 3-CH, 4-CH, 5-CH, half 6-CH2,
half 6-CH2
5.24(d), 3.56(dd), 3.70(t), 3.40(t), 3.83(m), 3.72(dd),
3.85(m)
b-glucose 1-CH, 2-CH, 3-CH, 4-CH, 5-CH, half 6-CH2,
half 6-CH2
4.65(d), 3.25 (dd), 3.47(t), 3.40(t), 3.47(ddd),
3.78(dd), 3.90(dd)
glutamate a-CH, b-CH2, c-CH2 3.78(m), 2.06(m), 2.36(m)
glutamine a-CH, b-CH2, c-CH2 3.78(m), 2.15(m), 2.46(m)
glycerol half a-CH2, half a-CH2, b-CH 3.56(dd), 3.64(dd), 3.87(m)
glycine Q (d12) CH2 3.55(s)
hypoxanthine 3-CH, 7-CH 8.10(s), 8.11(s)
isoleucine q (d26) a-CH, b-CH, half c-CH2, half c-CH2, d-CH3, b-CH3 3.68(d), 1.93(m), 1.25(m), 1.47(m), 0.99(d), 1.02(d)
lactate CH, CH3 4.12(q), 1.33(d)
leucine q (d8) a-CH, b-CH2, c-CH, d-CH3, d-CH3 3.72(t), 1.63(m), 1.69(m), 0.91(d), 0.94(d)
lysine a-CH, b-CH2, c-CH2, d-CH2, e-CH2 3.77(t), 1.92(m), 1.73(m), 1.47(m), 3.05(t)
methionine a-CH, b-CH2, c-CH2,C H 3 3.87(m), 2.10(m), 2.65(dd), 2.15(s)
myo-inositol 1,3-CH, 2-CH, 5-CH, 4,6-CH 3.53(dd), 4.06(t), 3.28(t), 3.63(t)
phenylacetic acid CH2, 2,4,6-CH, 3,5-CH 3.52(s), 7.29(t), 7.36(t)
phenylalanine 2,6-CH, 3,5-CH, 4-CH, half b-CH2, half b-CH2,
a-CH
7.44(m), 7.39(m), 7.33(m), 3.17(dd), 3.30(dd),
3.99(dd)
proline a-CH, half b-CH2, half b-CH2, c-CH2, d-CH2 4.15(dd), 2.05(m), 2.38(m), 2.00(m), 3.39(m)
propionate Q (d26) CH2,C H 3 2.19(q), 1.06(t)
succinate 26CH2 2.41(s)
threonine a-CH, b-CH, c-CH3 3.60(d), 4.26(m), 1.33(d)
tryptophan 4-CH, 7-CH, 2-CH, 5-CH, 6-CH, a-CH, half b-CH2,
half b-CH2
7.79(d), 7.56(d), 7.34(s), 7.29(t), 7.21(t), 4.06(dd),
3.49(dd), 3.31(dd)
tyrosine 2,6-CH, 3,5-CH, CH2, a-CH 7.23(d), 6.91(d), 2.93(t), 3.25(t)
uracil q (d8) 5-CH, 6-CH 5.81(d), 7.59(d)
urocanate a-CH, b-CH, 5-CH, 2-CH 6.40(d), 7.13(d), 7.41(s), 7.89(s)
valine q (d26) a-CH, b-CH, c-CH3, c9-CH3 3.62(d), 2.28(m), 0.98(d), 1.03(d)
Arrows indicate differences in the spectral profiles between E. caproni-infected mice and non-infected control mice (q, increased; Q, decreased in infected animals) and
the numbers in brackets show the day post-infection of maximum concentration difference of the respective metabolite. The p-values for the changing metabolites
were assessed using a non-parametric 1-way analysis of variance (Mann-Whitney U) test in MATLAB, based on the integrals of the selected peaks and were all in the
range of 0.001 to 0.05.
doi:10.1371/journal.pntd.0000254.t003
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Prior to assessing the metabolic effects of an E. caproni infection,
the
1H NMR spectra of plasma, stool, and urine samples obtained
from non-infected mice were characterized and found to be
inherently different in composition. All three types of biofluids
contained lactate, alanine, glucose, and acetate. Unique to the
urine metabolic profile was the presence of hippurate, indox-
ylsulfate, urocanate, taurine, trimethylamine-N-oxide (TMAO), 2-
oxoglutarate, ureidopropanoate, and 2-ketoisocaproate, amongst
others (Figure 1A, Figure 2A and Table 1). The plasma spectral
profiles were characterized by the predominance of various lipids
and lipoprotein fractions, along with resonances from creatine,
and several amino and organic acids (Figure 1B, Figure 2B and
Table 2). Apart from the standard 1D acquisition, applied on all
biofluids, a CPMG and diffusion edited pulse sequence was used in
plasma profiling, to represent low and high molecular weight
metabolites, respectively. Characteristic metabolic features of the
stool extracts were bile acids and short chain fatty acids (SCFAs),
such as butyrate, and propionate. In addition, other amino acids,
such as tryptophan, lysine, arginine, and glutamine were more
visible in stool spectra, compared to urine and plasma (Figure 1C,
Figure 2C and Table 3).
In order to establish whether excretory products of the parasite
itself were likely to contribute to any of the biofluids analyzed, a
standard 1D spectrum of an adult E. caproni was acquired. The
spectrum of the parasite differed from the biofluids obtained from
the mouse host in content of homocarnosine, histidinol, uridine,
pipecolate, and betaine (Figure 1D, Figure 2D), although betaine
has been observed in
1H NMR spectra of rodent urine in previous
studies [32]. Tables 1–4 summarize key metabolites found in
urine, plasma, and stool extracts of mice, and in the E. caproni
homogenate, respectively.
Multivariate analysis and global metabolic trajectories
In both PCA and PLS-DA scores plots of the urinary metabolite
profiles, a clear separation of E. caproni-infected and non-infected
control mice was already visible 1 day post-infection. This
separation was maintained in all later time points except day 5.
Table 4. List of main metabolites found in extracts of an adult E. caproni.
Metabolite Chemical moiety Chemical shift in ppm and multiplicity
3-hydroxybutyrate half a-CH2, half a-CH2, b-CH, c-CH3 2.32(m), 2.42(m), 4.16(m), 1.21(d)
acetate CH3 1.91(s)
alanine a-CH, b-CH3 3.81(q), 1.48(d)
betaine CH2,C H 3 3.90(s), 3.27(s)
choline 36CH3, a-CH2, b-CH2 3.21(s), 4.07(m), 3.52(m)
formate CH 8.45(s)
a-glucose 1-CH, 2-CH, 3-CH, 4-CH, 5-CH, half 6-CH2, half 6-CH2 5.24(d), 3.56(dd), 3.70(t), 3.40(t), 3.83(m), 3.72(dd), 3.85(m)
b-glucose 1-CH, 2-CH, 3-CH, 4-CH, 5-CH, half 6-CH2, half 6-CH2 4.65(d), 3.25(dd), 3.47(t), 3.40(t), 3.47(ddd), 3.78(dd), 3.90(dd)
glutamine a-CH, b-CH2, c-CH2 3.78(m), 2.15(m), 2.46(m)
glycerophosphocholine 36CH3, half a-CH2, half a-CH2, half b-CH2, half b-CH2, c-CH2 3.23(s), 4.32(t), 3.60(dd), 3.68(t), 3.89(m), 3.72(dd)
glycine CH2 3.55(s)
histidinol 5-CH, 3-CH, c-CH2, b-CH, a-CH 7.89(s), 7.12(s), 3.85(dd), 3.67(m), 3.62(m)
homocarnosine 5-CH, 3-CH, half ring-CH2, half ring-CH2, N-CH, N-CH2, CO-CH2,C H 2 7.90(s), 7.01(s), 3.17(dd), 2.96(dd), 4.48(m), 2.92(m), 2.36(m),
1.89(m)
isoleucine a-CH, b-CH, half c-CH2, half c-CH2, d-CH3, b-CH3 3.68(d), 1.93(m), 1.25(m),1.47(m), 0.99(d), 1.02(d)
lactate CH, CH3 4.12(q), 1.33(d)
leucine a-CH, b-CH2, c-CH, d-CH3, d-CH3 3.72(t), 1.63(m), 1.69(m), 0.91(d), 0.94(d)
lysine a-CH, b-CH2, c-CH2, d-CH2, e-CH2 3.77(t), 1.92(m), 1.73(m), 1.47(m), 3.05(t)
methionine a-CH, b-CH2, c-CH2,C H 3 3.87(m), 2.10(m), 2.65(dd), 2.15(s)
phenylalanine 2,6-CH, 3,5-CH, 4-CH, half b-CH2, half b-CH2, a-CH 7.44(m), 7.39(m), 7.33(m), 3.17(dd), 3.30(dd), 3.99(dd)
pipecolate half 3,4,5-CH2, half 4,5-CH2, half 3-CH2, half 6-CH2, half 6-CH2, 2-CH 1.60–1.66(m), 1.86(m), 2.22(m), 3.02(m), 3.43(m), 3.60(m)
proline a-CH, half b-CH2, half b-CH2, c-CH2, d-CH2 4.15(dd), 2.05(m), 2.38(m), 2.00(m), 3.39(m)
propionate CH2,C H 3 2.19(q), 1.06(t)
scyllo-inositol 66CH 3.35(s)
succinate 26CH2 2.41(s)
threonine a-CH, b-CH, c-CH3 3.60(d), 4.26(m), 1.33(d)
tryptophan 4-CH, 7-CH, 2-CH, 5-CH, 6-CH, a-CH, half b-CH2, half b-CH2 7.79(d), 7.56(d), 7.34(s), 7.29(t), 7.21(t), 4.06(dd), 3.49(dd),
3.31(dd)
tyrosine 2,6-CH, 3,5-CH, CH2, a-CH 7.23(d), 6.91(d), 2.93(t), 3.25(t)
uridine 6-CH, 5-CH, 29-CH, 39-CH, 49-CH, 59-CH(d), half CH2OH, half CH2OH 7.87(d), 5.90(s), 5.92(d), 4.36(t), 4.24(t), 4.14(q), 3.92(dd),
3.81(dd)
valine a-CH, b-CH, c-CH3, c9-CH3 3.62(d), 2.28(m), 0.98(d), 1.03(d)
doi:10.1371/journal.pntd.0000254.t004
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by taking the mean position in the principal component (PC)
scores plot for each group of mice (E. caproni-infected and non-
infected controls) separately, and connecting the coordinates
chronologically to establish any systematic change in metabolic
composition over the time course of the experiment. The control
group showed no significant movement over the study duration
(data not shown), whereas in the infected group, day 19 was
significantly separated from all other days post-infection, and the
whole time course of infection showed a shift from the upper left to
the lower right quadrant (Figure 3A), whereby days 1 and 5 post-
infection differed significantly from the sampling end point (day
33).
The plasma spectra of E. caproni-infected mice showed marked
differences at days 1, 12, 26, and 33 post-infection, with the best
discriminatory model at day 12 post-infection (goodness of
prediction (Q
2) according to PCA=0.97; Q
2Y (PLS-DA)=0.89).
Comparing the 3 different pulse programs applied, plasma time
trajectories, showed similar behavior. The control trajectories were
generally clustered, indicating stability of the metabolite compo-
sition over the study period. However, the standard 1D trajectory
showed a slight difference between early and late time points (e.g.,
day 1 was separated in space from days 19 to 33). In contrast, for
the E. caproni-infected animals, there was a significant metabolic
movement from early (day 1) to intermediate time points post-
infection (days 5 and 12) in the first component and finally to late
time points (days 26 and 33) in the third component (Figure 3B).
This movement pattern was consistent across the datasets acquired
by all three pulse programs.
With regard to the
1H NMR spectra obtained from stool
samples, a clear separation was found at day 5 post-infection in
both the PCA and PLS-DA scores plot between E. caproni-infected
and non-infected control mice, with maximum model fit for the
PLS-DA model at day 26 post-infection (Q
2=0.79). At the final
time point (day 33), the two groups were metabolically similar;
there was no separation between infected and non-infected mice
using PCA, and the PLS-DA model revealed a lower, but still
significant Q
2 value than all previous time points. By comparing
the time trajectories of the non-infected control with the E. caproni-
infected group of mice, the controls were more tightly clustered,
but showed a significant movement from day 8 post-infection
onwards along PC1. In the 2D time trajectory plot of the E. caproni-
Figure 4. Pair-wise comparison via O-PLS-DA between urine obtained from non-infected control mice (control) and E. caproni-
infected mice (infected) at 3 different sampling time points, i.e., day 8 (A), day 12 (B) and day 33 (C) post-infection. The color scale
indicates the relative contribution of the peak/region to the strength of the differentiation model and the peak intensity is measured relative to the
whole peak contribution in arbitrary units (a.u.). Note that the aromatic region (left part) is magnified by a factor 5.
doi:10.1371/journal.pntd.0000254.g004
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exception of days 8 and 12 post-infection, which comprised a
separate cluster (Figure 3C). Introducing an additional PC brought
about clear differentiation of the late time points (days 19, 26, and
33) from day 1 post-infection caused by more subtle systematic
variation in metabolic levels.
Pair wise comparison of time points across different
types of biofluids
O-PLS-DA was used to extract information on specific
metabolic changes induced by an E. caproni infection over the
duration of the study. Changes in urinary, plasma and fecal
metabolites are presented in Figures 4–6 for selected time points
and the complete set are summarized in Figure 7. Amongst the
most significantly changed urinary metabolites were hippurate
(decreased at day 33), 2-ketoisocaproate (decreased from day 8
onwards), trimethylamine (TMA; increased at days 8, 12, 19, and
33), taurine (decreased at days 8, 12, and 19), p-cresol glucuronide
(increased at days 8, 12, 19, and 26), mannitol (increased from day
5 onwards), TMAO (increased at days 8, and 12), phenylace-
tylglycine (increased from day 12 onwards), acetate (decreased at
days 8, and 19) and creatine (decreased at days 1, 5, 8, and 12).
Plasma from infected mice showed changes in the relative
concentration of acetate (increased at all time points except day 5),
creatine (decreased fromday8onwards),lipids(increased fromday8
onwards), formate (decreased at days 1, 8, 12, and 19, but increased
at day 33), lactate (decreased at days 1, 8, 12, 19, and 26), glucose
(increased at days 1, and 33, but decreased at days 12, 19, and 26),
glycerophosphorylcholine (GPC; decreased at days 12, 26, and 33),
choline (decreased at days 1, 12, 26, and 33) and branched chain
amino acids (BCAAs; decreased at days 12, 26, and 33).
The changes in stool samples from infected animals included the
BCAAs (increased at days 8, and 26), uracil (increased at day 8),
butyrate (decreased at days 12, 19, and 26), propionate (decreased at
days 12, 19, and 26) and 5-aminovalerate (increased from day 5
onwards).
Figure 5. Pair-wise comparison via O-PLS-DA between plasma CPMG spectra obtained from non-infected control mice (control) and
E. caproni-infected mice (infected) at 3 different sampling time points, i.e., day 8 (A), day 12 (B) and day 33 (C) post-infection. The
color scale indicates the relative contribution of the peak/region to the strength of the differentiation model and the peak intensity is measured
relative to the whole peak contribution in arbitrary units (a.u.). The CPMG spectrum represents small molecular weight components.
doi:10.1371/journal.pntd.0000254.g005
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over study duration
Figure 8 shows the relative concentration of some of these
metabolites both for control (blue) and infected mice (colored
according to biofluid). The error bars signify 2 SDs of the mean.
According to this 363 diagram, the selected plasma and urine
metabolites showed a more robust pattern of group separation
over time when compared to fecal water extracts. Whereas some
overlap was observed in the scores plot relating to the fecal water
samples, there was a tendency toward increasing discrimination of
urinary metabolites with time over the course of an E. caproni
infection, whereas the discrimination became smaller toward the
end of the experiment in the selected plasma metabolites.
Discussion
1H NMR-based metabolic profiling of biofluids is an established
method for deepening our understanding of host-parasite
interactions and for investigating disease states in clinical studies
[15,19,33]. Sample preparation and spectral acquisition of a
biofluid takes little time, and often an overview of the metabolic
state of the organism can be obtained by visual assessment of the
spectra. Identification of biomarkers from different types of
biofluids is similarly convenient, although stool samples need
slightly more preparation time and require sonication and an
additional centrifugation step, due to the high amount of
sediments in the stool-buffer mixture [34].
A number of potential biomarkers for diagnosis of an E. caproni
infection in the mouse were found here for each of the biofluids
employed; 12 in plasma, 10 in urine and 7 in stool. Hence, if for
practical purpose, a diagnosis was required based on a single
biofluid, either plasma or urine would be the first choice for
further development. Stool is the least suitable biological sample
not only in terms of a lower number of potential biomarkers, but
also because of the more difficult sample preparation, a lower
robustness of metabolites (Figures 7 and 8), and larger inter- and
intra-individual variation [34]. The latter issue makes it difficult to
determine if the change is related to the actual infection, or results
from other factors, e.g., age and/or microbiotal presence or
activity. Although the high degree of individual variation in the
fecal metabolite profiles derived from laboratory studies can be
overcome with parallel monitoring of metabolic time-related
Figure 6. Pair-wise comparison via O-PLS-DA between fecal water spectra obtained from non-infected control mice (control) and
E. caproni-infected mice (infected) at 3 different sampling time points, i.e., day 8 (A), day 12 (B) and day 33 (C) post-infection. The
color scale indicates the relative contribution of the peak/region to the strength of the differentiation model and the peak intensity is measured
relative to the whole peak contribution in arbitrary units (a.u.). Note that the aromatic region (left part) is magnified by a factor 5.
doi:10.1371/journal.pntd.0000254.g006
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future applications of metabonomics for diagnosis of parasitic
infections and disease states, and hence for monitoring disease
control programs. If the stability of the urine profiles compared to
plasma over the study duration is taken into account, then urine
would be the biofluid of choice on which to base a diagnostic.
Morevoer, urine collection is less invasive than blood collection.
Inter-group separation and trajectories
The time trajectories allow the influence of growth and
maturation of either host or parasite to be considered. Since very
few of the metabolites observed in the E. caproni fluke appeared in
any biofluid, infection-related changes are unlikely to correlate
with maturation of the parasite. Additionally, since the urinary
time trajectories were very different, comparing the control with
the infected group, whereas the control trajectory did not show
any significant movement over time; this would indicate that the
maturation of the host organism did not markedly influence the
metabolic profile over the 33-day time course. Hence, the systemic
movement over time observed in the infected group is most likely
to be related to the establishment and progression of the E. caproni
infection.
In stool and plasma, the time trajectories of the infected animals
demonstrated a markedly greater magnitude from the baseline
position than the non-infected animals. The greatest differentia-
tion between E. caproni-infected mice and non-infected control
animals was found in the PC scores plots based on the urine
spectral profiles. The smallest differentiation was observed in the
stool. From the scale of the PC scores plot axes the trajectory of the
infected group occupied a 1.5 and 50 times larger space for stool
and plasma, respectively than the non-infected group, whereas in
urine, the control trajectory occupied a 10
6 times bigger space,
compared to the trajectory of infection. The magnitude of
infection-induced metabolic disturbance in the urine profile again
clearly points to the greater suitability of urine as a diagnostic
biological matrix.
Intestinal re-absorption
The considerable increase in concentration of lipids in the
plasma, e.g., fatty acids, triaglycerols, and lipoproteins, reflects the
action of the parasite in the hosts gut. In mice harboring a 2-week-
old E. caproni-infection, an increased breakdown of membrane
lipids in the host intestinal tissue has been observed [35], which is
consistent with the present findings of a maximum lipid increase
on day 12 post-infection [36]. The excretory products of E. caproni
in the intestinal mucosa are primarily free sterols, triaglycerols,
and free fatty acids [37], but it is unlikely that the amounts
excreted by the parasite make a substantial contribution to the
host metabolic profile, given that the total parasite mass to host
weight ration is ,1:300.
Whilst the simple diffusion of lipid micelles into mucosal cells
seemsunaffectedbytheparasite,theNa
+-dependent active transport
of amino acids could be impaired as the increase of the BCAAs in
stool as the subsequent decreaseinplasma supports. Depletion of the
carrier molecules at the brush border of the mucosal cells, or a
change of the electrochemical gradient for Na
+ might explain the
selective impact on trans-luminal gut transport [38].
The observed decrease of leucine in plasma, in turn, might
induce the significant reduction in levels of 2-ketoisocaproate in
urine, which is a transamination product of the former [39].
Taurine is mainly conjugated with cholic acid and chenodeoxy-
cholic acid in the liver to form primary bile salts, and is excreted
via the urine after deconjugation from the bile salt or it leads into
the sulphur- or pyruvate metabolism. Once the taurine conjugated
bile salt has transformed the lipids into a micellar form, which is
necessary to cross the intestinal wall, taurine is deconjugated by
gut bacterial species and reabsorbed into the liver via blood
circulation [40]. The decreased levels of excreted taurine in the
urine of the infected mice may result from the higher demand for
increased lipid digestion, resulting from the action of E. caproni in
the gut.
Gut microbiota
The changes in hippurate, phenylacetylglycine, p-cresol-glucu-
ronide, and TMA in urine, and 5-aminovalerate, and the SCFA
levels in stool, are associated with a change in gut microbiotal
presence or activity, as all of these metabolites undergo
modification via gut microbial species before excretion. For
instance, 5-aminovalerate is formed by several different Clostridium
species which utilize ornithine and proline as substrates, but to our
knowledge, only C. aminovalericum degrades 5-aminovalerate further
to form mainly propionate and acetate [41–43]. This may imply
that the presence of E. caproni in the gut disturbs the microbial
balance resulting in depleted or inactivated C. aminovalericum. The
formation of p-cresol is likewise known to be performed by a
Clostridium subspecies (i.e., C. difficile and C. scatologenes) [44,45],
with the bacterium-specific enzyme p-hydroxyphenylacetate. It is
then conceivable that p-cresol is taken up by the bloodstream,
bound to serum proteins and glucuronidated in the kidney prior to
Figure 7. Summary of key E. caproni infection-related features
for urine (yellow), plasma (red), and fecal water (green). The
colored regions show the differences between E. caproni-infected mice
and non-infected control animals, whereas the changes in direction are
indicated by arrows (q, indicates an increase in the metabolite signal in
infected mice with respect to the control group; Q, indicates a
decreased metabolite signal in infected mice).
doi:10.1371/journal.pntd.0000254.g007
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be coupled with a higher activity or higher presence of this
bacterial strain as the kidney function does not seem to be
impaired in infected animals. PCR analyses on several different
Clostridium sub-strains are ongoing and will be discussed in
forthcoming publications.
The decrease of the SCFAs in stool may also be indicative of an
unbalanced microbiota, as dietary carbohydrates (e.g., starches and
fibres) are fermented by colonic bacteria to mainly acetate,
propionate, and butyrate. Whilst butyrate serves as main energy
source for colonocytes, acetate and propionate pass through the
intestinal wall and move via peripheral blood to the liver where they
have antagonistic functions on the cholesterol synthesis. Whilst the
former increases cholesterol synthesis, the latter was shown to act as
aninhibitor.Theuptakefromcolonbythebloodsystemisfourtimes
higher in the case of acetate, than propionate, which is a possible
explanation for depletion of theSCFA, also reflectedbytheobserved
decrease in levels of acetate in both urine and plasma [47,48].
The increased concentration of TMA and phenylacetylglycine,
and the decrease of hippurate in urine, observed at the later time
points of our experiment, are concomitant phenomena of the
changed gut microbiota [49,50]. Trimethylammonium compounds
like choline and carnitine, which are ingested in the normal diet, are
degraded by intestinal bacteria to TMA, and then oxidized in the
liver to TMAO in a second step [51,52]. A microbial shift toward
choline degrading bacteria might explain the choline/GPC
depletion in plasma and the subsequent increase of TMAO in urine.
Specificity of biomarkers for diagnosis
An infection with E. caproni induces changes in the concentra-
tion of a range of metabolites in urine, plasma, and stool. To be
useful as a ‘real’ biomarker, the metabolic candidate must be
reproducible, robust, specific and, ideally, easy to measure [53].
From the current analyses an anomalous increase in urinary
mannitol was noted in infected animals. Mannitol is likely to derive
from the diet, since it is not synthesized by vertebrates. However,
the higher amounts of urinary mannitol in E. caproni-infected mice,
may reflect the higher intestinal permeability, compared to the
control group [54].
To assess the specificity of the biomarkers identified for
potential diagnosis of infection, the obtained E. caproni fingerprint
was compared to altered metabolite patterns, associated with other
parasite-rodent models [16–18]. Interestingly, E. caproni seems to
alter the gut microbiota in a similar way to the biologically-related
blood flukes, i.e., S. mansoni [16], and S. japonicum [17]. Hippurate,
phenylacetylglycine, and TMA are modified by several gut
microbial species before excretion in urine. In the 3 disease
models, hippurate was found to decrease significantly, whereas
Figure 8. Statistical integration for 3 selected metabolites in the spectra of each of the 3 different types of biofluids (A, urine; B,
plasma; C, fecal water). The relative concentration with respect to the total spectral area of each of these metabolites is shown for non-infected
control mice (blue), and E. caproni-infected mice (yellow representing urine, red representing plasma, and green representing fecal water). The error
bars signify 2 standard deviations of the mean.
doi:10.1371/journal.pntd.0000254.g008
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increased levels in infections with all 3 parasites, which suggests
a common trematode-inherent influence on gut microbial
composition. The change in 2-ketoisocaproate in urine was unique
to the infection with E. caproni and 5-aminovalerate in stool may
also deliver an E. caproni-specific marker but, at the time being,
cannot be compared to other disease models, as the metabonomic
assessment of stool was applied only in the present parasite-rodent
model. The metabolic effect of a nematode infection (T. spiralis)i n
NIH Swiss mice has also been reported by Martin and colleagues
[18]. T. spiralis has a similar initial mechanism of pathogenicity
and also induces a state of inflammation of the gut before it
migrates from the intestine to muscle tissue and induces
hypercontractility [55]. While comparison between the study
conducted by Martin et al. [18] and the current study revealed a
number of biomarkers, which were the same in both models, the
directionality of these metabolites was different. For example, a
decrease in choline and creatine concentrations was observed in
E. caproni-infected mice, whereas the same metabolites were
reported to be increased in T. spiralis-infected mice compared to
non-infected controls. Furthermore, the lipids (e.g., triaglycerides,
saturated and unsaturated fatty acids) which undergo a marked
increase in E. caproni-infected animals, showed a significant
decrease in the mice infected with T. spiralis.
Future studies evaluating additional laboratory host-parasite
models, and applying complementary metabolic profiling meth-
ods, such as ultra performance liquid chromatography (UPLC), in
combination with mass spectrometry (MS), will help to confirm the
specificity of the metabolic perturbations associated with an
E. caproni infection. In conclusion, we have shown that metabolic
profiling of plasma, urine, and stool delivers a comprehensive
fingerprint of an E. caproni infection, composed of general as well as
highly specific biomarkers (e.g., 2-ketoisocaproate and 5-amino-
valerate). Keeping in mind the long-term objective of developing
novel diagnostic assays for trematode-borne diseases, one would
emphasize the value of further development, particularly based on
the urine profiles.
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